Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321. [electronic resource]
Producer: 20060314Description: 929-36 p. digitalISSN:- 1527-7755
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bone Marrow Transplantation
- Carmustine -- administration & dosage
- Chemotherapy, Adjuvant
- Clinical Protocols
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Drug Administration Schedule
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Interferons -- administration & dosage
- Male
- Melphalan -- administration & dosage
- Middle Aged
- Multiple Myeloma -- drug therapy
- Prednisone -- administration & dosage
- Prospective Studies
- Radiotherapy, Adjuvant
- Salvage Therapy -- methods
- Survival Analysis
- Transplantation, Autologous
- Transplantation, Homologous
- Treatment Failure
- Treatment Outcome
- United States
- Vincristine -- administration & dosage
- Whole-Body Irradiation
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.